Gene · 9133
Papers2,908
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,908
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Biomarkers of response to neoadjuvant palbociclib plus anastrozole in endocrine-resistant estrogen receptor-positive/HER2-negative breast cancer: a phase 2 trial. | Nat Commun | 2026 | 41593097 | PubTator, text mining | PubMed |
| Hypoxic glycolysis-driven histone lactylation activates NHE7 to promote endometrial cancer progression via COX6C-mediated endoplasmic reticulum stress. | Apoptosis | 2026 | 41575611 | PubTator, text mining | PubMed |
| Upcycling Fermented Adlay Bran Ethanol Extract Residues Promotes Human Dermal Fibroblast Proliferation and Wound Healing. | J Microbiol Biotechnol | 2026 | 41555511 | PubTator, text mining | PubMed |
| Construction of biomimetic gradient-structured cartilage organoids and mechanistic study of their application for cartilage rejuvenation. | Bioact Mater | 2026 | 41551764 | PubTator, text mining | PubMed |
| Identification of hub genes and construction of a survival prediction model for patients with nasopharyngeal carcinoma. | Sci Rep | 2026 | 41545643 | PubTator, text mining | PubMed |
| FOXM1 regulates platelet-induced anoikis resistance in pancreatic cancer cells. | Cell Commun Signal | 2026 | 41535944 | PubTator, text mining | PubMed |
| A comprehensive study integrating bioinformatics analysis and experimental results on HROB as a potential biomarker for the prognosis of lung adenocarcinoma. | Sci Rep | 2026 | 41526502 | PubTator, text mining | PubMed |
| Integrated multi-Omics and network toxicology elucidate the multi-target mechanisms of environmental hormones in driving hepatocellular carcinoma. | Ecotoxicol Environ Saf | 2026 | 41371106 | PubTator, text mining | PubMed |
| BUB1 and CCNB2 mediate cell cycle and inflammation, influencing the progression of oral squamous cell carcinoma. | J Stomatol Oral Maxillofac Surg | 2026 | 41151687 | PubTator, text mining | PubMed |
| An integrated bioinformatics approach to early diagnosis, prognosis and therapeutics of non-small-cell lung cancer. | J Biomol Struct Dyn | 2026 | 39535278 | PubTator, text mining | PubMed |
| Prognostic Significance of HMGA1 in Hepatocellular Carcinoma: Implications for Tumor Progression and Targeted Therapy. | Arch Iran Med | 2025 | 41778427 | PubTator, text mining | PubMed |
| Transcriptomics driven identification of hub gene miRNA interactions for biomarker and therapeutic target discovery in gynecological cancers. | Front Oncol | 2025 | 41561741 | PubTator, text mining | PubMed |
| Differential Gene Expression Across Species Following Spinal Cord Injury: A Systematic Review and Meta-Analysis. | Mol Neurobiol | 2025 | 41420753 | PubTator, text mining | PubMed |
| Cyclin B2 facilitates glycolysis and tumor progression in pancreatic ductal adenocarcinoma by promoting histone lactylation. | BMC Cancer | 2025 | 41353334 | PubTator, text mining | PubMed |
| Decoding cross-talk between Mpox and HIV: insights from transcriptomics and network-based analyses. | Virol J | 2025 | 41327255 | PubTator, text mining | PubMed |
| Potential Biomarkers and Therapeutic Targets of Non-Small Cell Lung Cancer. | Altern Ther Health Med | 2025 | 41289369 | PubTator, text mining | PubMed |
| Research on tracheal stenosis based on molecular biomarkers. | BMC Pulm Med | 2025 | 41272619 | PubTator, text mining | PubMed |
| The Anti-Cancer Potential of Genistein: Single-Cell RNA Sequencing Analysis and Spatial Transcriptome Reveal That Genistein Targets HSD17B1 to Inhibit the Progression of Gastric Adenocarcinoma. | Int J Mol Sci | 2025 | 41226409 | PubTator, text mining | PubMed |
| HROB is a novel prognostic biomarker correlated with immune cell infiltration and tumor progression in lung adenocarcinoma. | World J Surg Oncol | 2025 | 41184881 | PubTator, text mining | PubMed |
| Comprehensive bioinformatics analysis of omics data to reveal molecular mechanisms and biomarkers in multiple cancers. | In Silico Pharmacol | 2025 | 41113171 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9133/papers?page=3